Azalea Therapeutics
26 employees
Biotech/Pharma
Series A · $82.0M
Total raised
$82.0M
Last stage
Series A
Investors
Jenny Hamilton
Ph.D., spearheaded the EDV technology in the Doudna Lab at UC Berkeley; co-founder, president and chief executive officer of Azalea Therapeutics.
LinkedInJennifer Doudna
Ph.D., Nobel laureate in chemistry (2020), Li Ka Shing Chancellor's Chair at UC Berkeley, founder of the Innovative Genomics Institute.
Michael Fischbach
Ph.D., Liu (Liao) Family Professor of Bioengineering at Stanford University, institute scholar of Stanford ChEM-H.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.